View drug registration information details.
| Items | Registration information |
|---|
| ID | 1712 |
|---|
| No | 1712 |
|---|
| Brand Name | LUCIDASA |
|---|
| Ingredients | DASATINIB 50 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 60'S/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREAMENT OF NEWLY DIAGNOSED ADULTS WITH PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE, ADULT WITH CHRONIC, ACCELERATED, OR LYMPHOID BLAST PHASE PH+CML WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY INCLUDING IMATINIB, ADULT WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBASTIC LEUKEMIA WITH RESISTANCE OR INTOLERANCE TO PRIOR THERAPY, PEDIATRIC PATIENTS 1 YEAR OF AGE AND OLDER WITH PH+CML IN CHRONIC PHASE |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE TABLET |
|---|
| Note | |
|---|
| License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 02 L 1298/25 |
|---|
| FDD Registration Date | 25-FEB-2025 |
|---|
| Expiry Date | 24-FEB-2030 |
|---|
Back to drug list
|
